Under physiological hypoxic conditions (PO2 < 32 mmHg), HIF-1α signaling is crucial for the survival of CML LSCs treated with TKIs [125]. The gene discussed is HIF1A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.